HIMSS Analytics Honors NYU Langone Medical Center With The Emram Stage 7 Award, And Its Affiliated Practices With The Stage 7 Ambulatory Award

HIMSS Analytics has awarded NYU Langone Medical Center’s Tisch Hospital,Rusk Rehabilitation, and Hospital for Joint Diseases with its Stage 7 Award, and NYU Langone’s ambulatory practices with its Stage 7 Ambulatory Award. This is the first hospital enterprise in New York State to receive these prestigious awards.

Stage 7 Award: HIMSS Analytics developed the Electronic Medical Record (EMR) Adoption Model in 2005 as a methodology for evaluating the progress and impact of electronic medical record systems for hospitals in the HIMSS Analytics Database. There are eight stages (0-7) that measure a hospital’s implementation and utilization of information technology applications. The final stage, Stage 7, represents an advanced patient record environment. The validation process to confirm a hospital has reached Stage 7 includes a site visit by an executive from HIMSS Analytics and former or current chief information officers and chief medical information officers to ensure an unbiased evaluation of the Stage 7 environments.

Stage 7 Ambulatory Award: Developed in 2011, the Ambulatory EMR Adoption Model provides a methodology for evaluating the progress and impact of electronic medical record systems for ambulatory facilities owned by hospitals in the HIMSS Analytics Database. These facilities include physician practices, clinics, outpatient centers and specialty clinics. Tracking their progress in completing eight stages (0-7), ambulatory facilities can review the implementation and use of IT applications with the intent of reaching Stage 7, which represents an advanced electronic patient record environment.

“The Stage 7 awards signify the highest and most optimized level of EHR adoption in NYU Langone's hospital setting and across the ambulatory network, which includes leveraging and governing health data and analytics, computer order entry & electronic documentation, paperless registration, and patient engagement,” saidNader Mherabi, senior vice president and vice dean, chief information officer at NYU Langone Medical Center. “The technology both demands and enables precise information sharing between healthcare providers and patients, and is critical to achieving NYU Langone’s commitment to providing world-class medicine.”

During the fourth quarter of 2015, only 4.2 percent of the more than 5,400 U.S. hospitals in the HIMSS Analytics Logic received the Stage 7 Award, and only 7.89 percent of the more than 36,000 ambulatory clinics in HIMSS Analytics Logic received the Stage 7 Ambulatory Award.

“NYU Langone is the first organization in the State of New York to achieve Stage 7 of the acute care and ambulatory EMRAM. Their successful bundled payment program along with their commercial and public payor registries demonstrates they are ready to thrive in a value-based care payment environment,” said John H. Daniels, CNM, FACHE, FHIMSS, CPHIMS, global vice president, healthcare advisory services group, HIMSS Analytics.

NYU Langone Medical Center is one of the nation’s premier centers for excellence in clinical care, biomedical research, and medical education. Located in the heart of Manhattan, NYU Langone is composed of five hospitals—Tisch Hospital, its flagship acute care facility; Rusk Rehabilitation; the Hospital for Joint Diseases, the Medical Center’s dedicated inpatient orthopaedic hospital; NYU Lutheran Medical Center, a full-service, 450-bed teaching hospital located in Brooklyn, and Hassenfeld Children’s Hospital, a comprehensive pediatric hospital supporting a full array of children’s health services across the Medical Center. Also part of NYU Langone is NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history, and the Laura and Isaac Perlmutter Cancer Center, a National Cancer Institute–designated cancer center

NYU Langone Medical Center will be recognized at the 2017 Annual HIMSS Conference & Exhibition on Feb. 19-23 2017, in Orlando, Fla.

Visit the HIMSS Analytics web site for more information on the Stage 7 award and Stage 7 Ambulatory Award.

About HIMSS Analytics
HIMSS Analytics collects, analyzes and distributes essential health IT data related to products, costs, metrics, trends and purchase decisions. It delivers quality data and analytical expertise to healthcare delivery organizations, IT companies, governmental entities, financial, pharmaceutical and consulting companies. Visit www.himssanalytics.org.

HIMSS Analytics is a part of HIMSS, a cause-based, global enterprise that produces health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share the cause of transforming health and healthcare through the best use of IT. HIMSS, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.